Venus remedies

  • Published on
    15-Jul-2015

  • View
    828

  • Download
    0

Embed Size (px)

Transcript

<ul><li><p> BSE Code : 526953NSE Code : VENUSREMSector : PHARMACEUTICALSReport date : Thu Apr 24 06:51:51 EDT 2014 </p><p>Industry overview </p><p>Market CapMarket Cap is the price ofall the outstandingcommon shares if we wereto buy it all at the currentprice</p><p>347.61 Cr</p><p>The benchmark companySun Pharma in thepharmaceuticals sector is374 times the size ofVenus Remedies</p><p>Small Caps are a choicefor people who can handlehigh volatility/risk with veryhigh chance of returns</p><p>1</p></li><li><p>Stock AnalysisGrowth AnalysisCompanies that have grown historically are more likely to exibit similar growth in the future. Readthe trends in the 4 year annualized profit growth, book value growth and sales growth shownbelow: </p><p>How good are the returns?RoE is the speed at which the company might grow without sorting to additional fund raising.RoCE is the growth speed, if the company used all the assets, including loans/preference shares.The 2-year and 4-year values give a reasonable assurance about the growth sustenance. </p><p>KEY</p><p>KEY</p><p>2</p></li><li><p>Piotroski ScoreSeperate Winners from LosersThe Piotroski scoring system is a nine point system to determine the strength of a firm's financialposition. The score was developed by an accounting professor out of Chicago named JosephPiotroski. If it scores an 8 or 9, then the fundamentals are great for the stock. </p><p>Score: 7/9</p><p>3</p></li><li><p>DISCLAIMER </p><p>This report is prepared by the good.inve.story. software and is not prepared by anactual person who has a CFA or any other certification. </p><p>good.inve.story. is still in BETA mode. So, please let us know if you find any errors.We would love to hear from you. </p><p>This report is based on information obtained from public sources and sourcesbelieved to be reliable, but no independent verification has been made nor is itsaccuracy or completeness guaranteed. </p><p>This report is not an advisory to buy or sell. Please buy only if you think, this is theright company at the right price and sell only if you dont see any potential forupside. </p><p>get more @ goodinvestory.com</p><p>4</p><p>Stock AnalysisGrowth AnalysisHow good are the returns?</p><p>Piotroski ScoreSeperate Winners from Losers</p></li></ul>